share_log

强生终止一种膀胱癌药物的晚期研究

Gelonghui Finance ·  Oct 8 03:21

格隆汇10月8日|强生公司周一表示,已经终止了对一种治疗膀胱癌的实验性药物的晚期研究,原因是与化学放疗相比,该药物没有显示出更大的优势。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment